RxCelerate

RxCelerate provides outsourced drug discovery and development services with expertise spanning small molecules and biologics. The company offers bespoke experimental design, integrated project management, and proprietary technology platforms to accelerate client assets from early discovery through preclinical development. They do not develop their own drugs but support clients' programs toward proof-of-concept or IND submission with flexible scientific solutions tailored to each project’s needs. Their technologies include rapid in silico screening tools and advanced proteomics/antibody platforms. Clients range from early-stage biotech startups to established pharma companies.